Drug cocktail tested to extend lives in liver cancer
NCT ID NCT07321613
Summary
This study looked back at medical records to see if adding three oral medications (thalidomide, carmofur, and compound mylabris capsules) to a standard liver cancer procedure (TACE) helped patients live longer. It involved 545 people with advanced liver cancer that couldn't be removed by surgery. Researchers compared survival times between those who got the drug combination plus the procedure and those who got the procedure alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CANCER (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, China
Conditions
Explore the condition pages connected to this study.